[血管外科的细菌体 - - 对移植感染的替代疗法治疗方法]
Theresa Angles1, Simon Junghans2, Justus Groß1
1Klinik und Poliklinik für Allgemein-, Viszeral-, Thorax-, Gefäß- und Transplantationschirurgie, Universitätsmedizin Rostock, Rostock, Deutschland.
Zentralblatt fur Chirurgie
|January 23, 2026
概括
菌体治疗为治疗血管移植感染提供了一种新的方法,有可能避免风险大的手术. 这篇评论探讨了它的历史,挑战和在9个患者病例中的使用.
科学领域:
- 传染性疾病 传染性疾病
- 血管外科 血管外科
- 微生物学 微生物学
背景情况:
- 血管移植感染是一种严重并发症,患病率和死亡率高.
- 目前的治疗方法,如移植切除和抗生素,由于患者的风险和抗生素耐药性,具有局限性.
- 菌体 (针对细菌的病毒) 是一个有希望的替代抗感染策略.
研究的目的:
- 审查细菌治疗的历史,生物学和挑战.
- 为了总结现有的病例报告,关于血管移植感染的细菌治疗.
- 探索菌体作为一种高风险的外科手术的替代品,用于移植感染.
主要方法:
- 关于细菌治疗的文献综述.
- 对9份已发表的病例报告/细菌治疗血管移植感染的系列病例报告进行分析.
- 专注于使用菌体来避免移植物扩张的情况.
主要成果:
- 菌体治疗有着悠久的历史,但在西方医学中临床研究有限.
- 九个病例证明了菌体在治疗血管移植感染中的使用.
- 这种方法旨在规避高风险的移植外科手术.
结论:
- 菌体治疗是治疗血管移植感染的潜在策略.
- 它为那些不适合进行大规模手术的高风险患者提供了一个替代方案.
- 需要进一步的临床研究来确定其有效性和安全性.
相关概念视频
Lysogenic Cycle of Bacteriophages
67.5K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.5K
Lytic Cycle of Bacteriophages
77.6K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.6K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
181
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
181
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
178
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
178
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
160
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
160
DNA Bacteriophages
882
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
882


